The Fiocruz institute in Rio de Janeiro has confirmed that a patient isolated over the weekend with symptoms resembling Ebola does not have the virus. Tests instead revealed malaria. The man, a Belgian national who arrived from Uganda, presented with cough, chills, and diarrhoea. He was placed under strict biosafety protocols following his admission on Saturday. Subsequent analysis of blood, saliva, and urine samples returned negative for Ebola, allowing his release from isolation.

The case drew attention to the transcontinental journey the patient undertook. He flew from Johannesburg to São Paulo’s Guarulhos airport on 22 May, then travelled by bus to Rio, where he stayed in the Vila Isabel neighbourhood. Brazilian health authorities monitored five contacts who remained asymptomatic. Officials noted that while in Uganda, he did not visit outbreak zones or have contact with known cases, a detail that eased early concern.

A second suspected case in São Paulo continues to be investigated. A 37-year-old man, reported as having arrived from the Democratic Republic of Congo, was isolated with fever and later diagnosed with a severe form of meningitis. He is undergoing further tests to definitively exclude Ebola. The simultaneous alerts underscore the high state of vigilance in Brazil, a country that has strengthened its infectious disease surveillance after past epidemics.

Viewed from a broader perspective, the incidents are a reminder of the ongoing Ebola threat in central and eastern Africa. According to the African Union, there have been 1,077 suspected cases and 246 deaths in the current outbreak, primarily affecting Uganda and the DRC. Global health systems remain on alert; the quick diagnostic turnaround in Rio exemplifies the effectiveness of reference laboratories, but the São Paulo case highlights the clinical difficulty of differentiating haemorrhagic fevers from other tropical diseases.

As long as Ebola circulates in Africa, the risk of imported cases will persist. Brazilian officials have not disclosed the timeline for clearing the São Paulo patient, but the rapid exclusion of Ebola in Rio suggests that robust protocols can swiftly allay public fears. The coming days will test the São Paulo laboratory’s capabilities, but the dual episodes are likely to reinforce calls for strengthened global health security cooperation, particularly in Latin American nations that serve as transit hubs.